BRC News

A pilot service at UCLH set up by clinicians and researchers that enables ear, nose and throat (ENT) surgeons to assess hearing and ear problems remotely and shorten treatment pathways has won the ENT UK’s Best Young Consultant Led Research, Audit or Training prize.

The BRC has published a magazine for patients and the public on the latest research at UCLH

Being a young adult aged 18 to 24 is a more important risk factor for weight gain than sex, ethnicity, geographic region, or socioeconomic area characteristics, according to a new study.

An antibody treatment trialled at UCLH cuts the risk of developing symptomatic COVID-19 by 77%.

Researchers are applying AI technology to ‘unlock’ data held in patients’ health records so that it can be used to improve care, planning and research.

UCLH is the highest recruiter among UCLPartners (UCLP) organisations in 2021 to clinical trials run in conjunction with the healthcare company IQVIA.

In a collaboration between UCLH and Imperial College, researchers have developed a new test which could help doctors more easily distinguish what kind of infection a patient may have and prescribe treatments more quickly.

Patient and public involvement (PPI) training brings about immediate and marked increases in the confidence and skills of researchers to involve the public in their work, according to a study at the BRC.

A national study involving UCLH has deepened understanding of the symptoms, signs and outcomes of patients with the novel condition vaccine-induced immune thrombocytopenia and thrombosis (VITT), associated with the Oxford/AstraZeneca vaccine.

UCLH is carrying out a three-month assessment of its delivery of race equality in health research as part of a project led by the National Institute of Health Research (NIHR).

UCLH and Cambridge University in collaboration with NHS Blood and Transplant have won government funding to apply artificial intelligence (AI) to improve blood transfusions.

A new UCLH and UCL-led observational study of patients with cerebral venous thrombosis (CVT) following COVID-19 vaccination provides a clearer guide to clinicians trying to diagnose and treat patients.

Antibodies produced by SARS-CoV-2 variants differ in their ability to neutralise other variants of the virus, according to research by UCLH and the Francis Crick Institute.

The first clinical trial of a new dietary treatment for children and adults with severe forms of epilepsy, co-developed by UCL researchers and based on the ketogenic diet, has been successfully completed.

Blood cancer patients are at increased risk of severe disease  from Covid-19 and less likely to be protected by vaccination